Clinical Trial

Trial Protocol ID USOR 24100_FTH-PIK-201

Trial Description

An Open-label, Multi-Center, Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) with Paclitaxel, and a Substudy Evaluating PIKTOR with Paclitaxel plus an Insulin-Suppressing Diet, in Patients with Advanced or Recurrent Endometrial Cancer (FTH-PIK-201)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Danubia Hester, MD

Disease Types

Sponsor

  • FAETH Therapeutics, Inc.

ClinicalTrials.gov NCT ID

  • NCT06463028